Literature DB >> 22481048

Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy.

Andrea Frustaci, Emanuela Morgante, Daniela Antuzzi, Matteo Antonio Russo, Cristina Chimenti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22481048     DOI： 10.1016/j.ijcard.2012.03.112

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  14 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review.

Authors:  Emer Joyce; Aurelie Fabre; Niall Mahon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-03

3.  Electrospun Polydioxanone Loaded With Chloroquine Modulates Template-Induced NET Release and Inflammatory Responses From Human Neutrophils.

Authors:  Allison E Fetz; Shannon E Wallace; Gary L Bowlin
Journal:  Front Bioeng Biotechnol       Date:  2021-04-27

4.  Use of Hydroxychloroquine and Risk of Heart Failure in Patients With Rheumatoid Arthritis.

Authors:  Ahmed A Sorour; Reto D Kurmann; Youssef E Shahin; Cynthia S Crowson; Sara J Achenbach; Rekha Mankad; Elena Myasoedova
Journal:  J Rheumatol       Date:  2021-01-15       Impact factor: 5.346

Review 5.  Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.

Authors:  Ohad Oren; Eric H Yang; Ty J Gluckman; Erin D Michos; Roger S Blumenthal; Bernard J Gersh
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-05-21

Review 6.  Repositioned Drugs for COVID-19-the Impact on Multiple Organs.

Authors:  Sean T Foster; Kayla G Chan; Matthew J Cacace; Shay L Ladd; Christina Chan; Caleb T Sandum; Paul T Wright; Brett Volmert; Weiyang Yang; Aitor Aguirre; Wen Li; Neil T Wright
Journal:  SN Compr Clin Med       Date:  2021-04-21

Review 7.  Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.

Authors:  Romain Muller
Journal:  Rheumatol Int       Date:  2021-04-24       Impact factor: 2.631

Review 8.  Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?

Authors:  Priyanka Pahan; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2020-05-15       Impact factor: 4.147

9.  Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID-19 Epidemic.

Authors:  Serena Romani; Alexandre Gérard; Audrey Fresse; Delphine Viard; Élise Van-Obberghen; Joëlle Micallef; Fanny Rocher; Milou-Daniel Drici
Journal:  Clin Transl Sci       Date:  2020-10-23       Impact factor: 4.689

Review 10.  Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.

Authors:  Pankaj Bansal; Amandeep Goyal; Austin Cusick; Shubham Lahan; Harpal S Dhaliwal; Poonam Bhyan; Pradnya Brijmohan Bhattad; Fawad Aslam; Sagar Ranka; Tarun Dalia; Lovely Chhabra; Devang Sanghavi; Bhavin Sonani; John M Davis
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.